{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:37:52Z","timestamp":1792791472758,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,3]],"date-time":"2021-03-03T00:00:00Z","timestamp":1614729600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["206379\/Z\/17\/Z"],"award-info":[{"award-number":["206379\/Z\/17\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["85810"],"award-info":[{"award-number":["85810"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI116155"],"award-info":[{"award-number":["R01AI116155"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 AI068632"],"award-info":[{"award-number":["U01 AI068632"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UM1 AI068634"],"award-info":[{"award-number":["UM1 AI068634"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UM1 AI068636"],"award-info":[{"award-number":["UM1 AI068636"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UM1 AI106701"],"award-info":[{"award-number":["UM1 AI106701"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007112","name":"University of Cape Town","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007112","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.ijid.2021.03.001","type":"journal-article","created":{"date-parts":[[2021,3,7]],"date-time":"2021-03-07T06:57:57Z","timestamp":1615100277000},"page":"688-694","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"special_numbering":"C","title":["Neuropsychiatric toxicity and cycloserine concentrations during treatment for multidrug-resistant tuberculosis"],"prefix":"10.1016","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7927-6506","authenticated-orcid":false,"given":"Richard","family":"Court","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7289-534X","authenticated-orcid":false,"given":"Chad M.","family":"Centner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1685-4882","authenticated-orcid":false,"given":"Maxwell","family":"Chirehwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubbe","family":"Wiesner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7494-079X","authenticated-orcid":false,"given":"Paolo","family":"Denti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7015-7247","authenticated-orcid":false,"given":"Nihal","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Harding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7592-8012","authenticated-orcid":false,"given":"Tawanda","family":"Gumbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Maartens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"McIlleron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10150","key":"10.1016\/j.ijid.2021.03.001_bib0005","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0140-6736(18)31644-1","article-title":"Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis","volume":"392","author":"Ahmad","year":"2018","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ijid.2021.03.001_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.00055-19","article-title":"Cycloserine population pharmacokinetics and pharmacodynamics in patients with tuberculosis","volume":"63","author":"Alghamdi","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.ijid.2021.03.001_bib0015","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/mpr.351","article-title":"The psychometric properties of the K10 and K6 scales in screening for mood and anxiety disorders in the South African Stress and Health study","volume":"20","author":"Andersen","year":"2011","journal-title":"Int J Methods Psychiatr Res"},{"issue":"9","key":"10.1016\/j.ijid.2021.03.001_bib0020","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S1473-3099(10)70139-0","article-title":"Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis","volume":"10","author":"Caminero","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.ijid.2021.03.001_bib0025","doi-asserted-by":"crossref","first-page":"27","DOI":"10.5588\/ijtld.13.0375","article-title":"Sensory polyneuropathy in human immunodeficiency virus-infected patients receiving tuberculosis treatment","volume":"18","author":"Centner","year":"2014","journal-title":"Int J Tuberc Lung Dis"},{"issue":"11","key":"10.1016\/j.ijid.2021.03.001_bib0030","doi-asserted-by":"crossref","first-page":"e01381","DOI":"10.1128\/AAC.01381-20","article-title":"Population pharmacokinetics of cycloserine and pharmacokinetic\/pharmacodynamic target attainment in multidrug-resistant tuberculosis patients dosed with terizidone","volume":"64","author":"Chirehwa","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.ijid.2021.03.001_bib0035","doi-asserted-by":"crossref","first-page":"24","DOI":"10.7196\/samj.6455","article-title":"Prevalence and incidence of symmetrical symptomatic peripheral neuropathy in patients with multidrug-resistant TB","volume":"104","author":"Conradie","year":"2014","journal-title":"South African Med J"},{"issue":"1","key":"10.1016\/j.ijid.2021.03.001_bib0040","doi-asserted-by":"crossref","first-page":"30","DOI":"10.5588\/ijtld.17.0475","article-title":"Steady state pharmacokinetics of cycloserine in patients on terizidone for multidrug-resistant tuberculosis","volume":"22","author":"Court","year":"2018","journal-title":"Int J Tuberc Lung Dis"},{"issue":"July (1)","key":"10.1016\/j.ijid.2021.03.001_bib0045","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1600-0404.1987.tb03536.x","article-title":"Characteristics of pyridoxine overdose neuropathy syndrome","volume":"76","author":"Dalton","year":"1987","journal-title":"Acta Neurol Scand"},{"issue":"Suppl 3","key":"10.1016\/j.ijid.2021.03.001_bib0050","doi-asserted-by":"crossref","first-page":"S308","DOI":"10.1093\/cid\/ciy624","article-title":"D-Cycloserine Pharmacokinetics\/Pharmacodynamics, Susceptibility, and dosing implications in multidrug-resistant tuberculosis: a Faustian deal","volume":"67","author":"Deshpande","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"November (2)","key":"10.1016\/j.ijid.2021.03.001_bib0055","first-page":"157","article-title":"Considerations on cycloserine in the treatment of pulmonary tuberculosis","volume":"24","author":"Desmeules","year":"1957","journal-title":"Laval Med"},{"issue":"9","key":"10.1016\/j.ijid.2021.03.001_bib0060","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1164\/rccm.201711-2333OC","article-title":"Drug-penetration gradients associated with acquired drug resistance in patients with tuberculosis","volume":"198","author":"Dheda","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijid.2021.03.001_bib0065","series-title":"Division of AIDS (DAIDS) Table for Grading the Severity of Adult and Pediatric Adverse Events","author":"Division of AIDS","year":"2017"},{"issue":"5","key":"10.1016\/j.ijid.2021.03.001_bib0070","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.tube.2010.07.002","article-title":"Cerebrospinal fluid concentrations of antituberculosis agents in adults and children","volume":"90","author":"Donald","year":"2010","journal-title":"Tuberculosis"},{"key":"10.1016\/j.ijid.2021.03.001_bib0075","series-title":"\u2018Five of our patients have attempted to take their own lives\u2019. The Guardian","author":"Emily Wise","year":"2013"},{"issue":"04","key":"10.1016\/j.ijid.2021.03.001_bib0080","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1192\/bjp.187.4.366","article-title":"Clinical implications of brief psychiatric rating scale scores","volume":"187","author":"Etschel","year":"2005","journal-title":"Br J Psychiatry"},{"issue":"1","key":"10.1016\/j.ijid.2021.03.001_bib0085","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/oxfordjournals.aje.a009909","article-title":"Alcohol intake assessment: the sober facts","volume":"150","author":"Feunekes","year":"1999","journal-title":"Am J Epidemiol"},{"issue":"1","key":"10.1016\/j.ijid.2021.03.001_bib0090","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/CND.0000000000000049","article-title":"Revisiting the evidence for neuropathy caused by pyridoxine deficiency and excess","volume":"16","author":"Ghavanini","year":"2014","journal-title":"J Clin Neuromuscul Dis"},{"key":"10.1016\/j.ijid.2021.03.001_bib0095","article-title":"Chemotherapy of tuberculosis, Mycobacterium avium complex disease, and leprosy","volume":"vol. 13","author":"Gumbo","year":"2018"},{"key":"10.1016\/j.ijid.2021.03.001_bib0100","first-page":"220","article-title":"Side effects of cycloserine","volume":"71","author":"Helmy","year":"1970","journal-title":"Scand J Respir Dis Suppl"},{"issue":"8","key":"10.1016\/j.ijid.2021.03.001_bib0105","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1021\/ja01613a106","article-title":"Structure and reactions of cycloserine","volume":"77","author":"Hidy","year":"1955","journal-title":"J Am Chem Soc"},{"issue":"6","key":"10.1016\/j.ijid.2021.03.001_bib0110","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1378\/chest.36.6.591","article-title":"The role of the cycloserine (seromycin) blood level in the treatment of pulmonary tuberculosis and the prevention and control of cycloserine (seromycin) toxicity","volume":"36","author":"Holmes","year":"1959","journal-title":"Dis Chest"},{"issue":"5","key":"10.1016\/j.ijid.2021.03.001_bib0115","doi-asserted-by":"crossref","first-page":"601","DOI":"10.5588\/ijtld.13.0268","article-title":"Serum concentrations of cycloserine and outcome of multidrug-resistant tuberculosis in Northern Taiwan","volume":"18","author":"Hung","year":"2014","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijid.2021.03.001_bib0120","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.5588\/ijtld.12.0863","article-title":"Safety of cycloserine and terizidone for the treatment of drug-resistant tuberculosis: a meta-analysis","volume":"17","author":"Hwang","year":"2013","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijid.2021.03.001_bib0125","article-title":"Psychological side effects induced by cycloserine in the treatment of pulmonary tuberculosis","volume":"73","author":"Kendig","year":"1956","journal-title":"Am Rev Tuberc"},{"key":"10.1016\/j.ijid.2021.03.001_bib0130","unstructured":"Kessler R. Kessler Psychological Distress Scale (K10) [Internet]; [cited 2020 April 15]. Available from: https:\/\/www.tac.vic.gov.au\/files-to-move\/media\/upload\/k10_english.pdf."},{"issue":"April (2)","key":"10.1016\/j.ijid.2021.03.001_bib0135","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/00063110-200504000-00007","article-title":"Pyridoxine in clinical toxicology: a review","volume":"12","author":"Lheureux","year":"2005","journal-title":"Eur J Emerg Med"},{"issue":"3","key":"10.1016\/j.ijid.2021.03.001_bib0140","doi-asserted-by":"crossref","first-page":"565","DOI":"10.4269\/ajtmh.2010.09-0629","article-title":"Implementation of a validated peripheral neuropathy screening tool in patients receiving antiretroviral therapy in Mombasa, Kenya","volume":"83","author":"Mehta","year":"2010","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"10.1016\/j.ijid.2021.03.001_bib0145","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3122\/jabfm.17.5.309","article-title":"The prevalence, predictors, and consequences of peripheral sensory neuropathy in older patients","volume":"17","author":"Mold","year":"2004","journal-title":"J Am Board Fam Pract"},{"key":"10.1016\/j.ijid.2021.03.001_bib0150","article-title":"A pilot study of cycloserine toxicity: a United States Public Health Service cooperative clinical investigation","volume":"74","author":"Murray","year":"1956","journal-title":"Am Rev Tuberc"},{"issue":"10","key":"10.1016\/j.ijid.2021.03.001_bib0155","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.35.10.1466","article-title":"Sensory neuropathy with low-dose pyridoxine","volume":"35","author":"Parry","year":"1985","journal-title":"Neurology"},{"issue":"16","key":"10.1016\/j.ijid.2021.03.001_bib0160","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/00002030-200202150-00012","article-title":"Severity of HIV-associated neuropathy is associated with plasma HIV-1 RNA levels","author":"Simpson","year":"2002","journal-title":"AIDS"},{"issue":"March (3)","key":"10.1016\/j.ijid.2021.03.001_bib0165","first-page":"514","article-title":"Some considerations of cycloserine toxicity","volume":"75","author":"Storey","year":"1957","journal-title":"Am Rev Tuberc"},{"issue":"6","key":"10.1016\/j.ijid.2021.03.001_bib0170","doi-asserted-by":"crossref","first-page":"722","DOI":"10.5588\/ijtld.10.0284","article-title":"Polyneuropathy, anti-tuberculosis treatment and the role of pyridoxine in the HIV\/AIDS era: a systematic review","volume":"15","author":"Van Der Watt","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"issue":"September (9)","key":"10.1016\/j.ijid.2021.03.001_bib0175","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s40264-018-0664-0","article-title":"Vitamin B6 in Health supplements and neuropathy: case series assessment of spontaneously reported cases","volume":"41","author":"van Hunsel","year":"2018","journal-title":"Drug Saf"},{"key":"10.1016\/j.ijid.2021.03.001_bib0180","series-title":"Notes on the Design of Bioequivalence Study: Terizidone","author":"WHO","year":"2015"},{"key":"10.1016\/j.ijid.2021.03.001_bib0185","series-title":"WHO consolidated guidelines on drug-resistant tuberculosis treatment","author":"WHO","year":"2019"},{"key":"10.1016\/j.ijid.2021.03.001_bib0190","series-title":"South African department of health. Management of drug resistant tuberculosis","year":"2013"},{"key":"10.1016\/j.ijid.2021.03.001_bib0195","unstructured":"Brief Psychiatric Rating Scale [Internet]. [cited 2020 April 7]. Available from: https:\/\/www.sciencedirect.com\/topics\/medicine-and-dentistry\/brief-psychiatric-rating-scale."}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S120197122100206X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S120197122100206X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T08:04:12Z","timestamp":1761120252000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S120197122100206X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":39,"alternative-id":["S120197122100206X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2021.03.001","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuropsychiatric toxicity and cycloserine concentrations during treatment for multidrug-resistant tuberculosis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2021.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}